Related Experiment Video
Updated: Jul 12, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme
Vincenzo Guarcello1, Carmelo Blanquicett, Fardos N M Naguib
1Department of Pharmacology and Toxicology, Comprehensive Cancer Center, Center for AIDS Research, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Purpose:
Thymidine phosphorylase (TP, EC 2.4.2.4) activity varies in different human cancer cell lines. Nevertheless, little is known about the regulatory mechanisms of TP expression in such cancers. Promoter methylation of dinucleotide cytosine-guanine (CpG) sites is a known mechanism of reversible gene expression silencing.
Methods:
TP promoter methylation was investigated in five cancer cell lines (SKBR-3, 786-O, HT-29, MDA-231, DLD-1). TP mRNA levels were determined by real-time quantitative PCR. The degree of methylation was identified by bisulfite sequencing. Minimal TP promoter activity was determined by Luciferase reporter assays. DNA-protein interactions were evaluated by electrophoretic mobility shift assays.
Results:
SKBR-3 cells exhibited the highest TP expression, 786-O, HT-29, and MDA-231 cells exhibited intermediate TP expression, while DLD-1 cells did not express TP as demonstrated by TP mRNA, protein, and enzyme activity levels. SKBR-3 lacked methylation in the TP promoter, intron 1 and exon 1 regions, while DLD-1 showed extensive methylation. Treatment of DLD-1 and SKBR-3 with the methylation-inhibitor, 5-aza-2'-deoxycytidine (5-aza-2dC), resulted in a concentration-dependent increase in TP mRNA and protein levels in DLD-1 but not SKBR-3 cells. Trichostatin-A treatment, a histone deacetylase inhibitor, improved the 5-aza-2dC-induced TP re-activation. Electrophoretic mobility shift assays demonstrated that methylation significantly inhibits transcription factor binding. Supershift analyses suggest that the Sp1 and Sp3 (to a lesser degree) transcription factors have a role in the regulation of TP expression.
Conclusions:
These findings suggest that TP promoter methylation is a mechanism for down-regulation of TP expression in cancer cells and may have implications in modulating prognosis of cancer patients.
Insights
Thymidine phosphorylase (TP) expression in cancer is regulated by promoter methylation. Inhibiting methylation reactivates TP, suggesting its role in cancer prognosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Thymidine phosphorylase (TP) activity varies across human cancer cell lines.
- Mechanisms regulating TP expression in cancer remain largely unknown.
- Promoter methylation is a known mechanism for reversible gene silencing.
Purpose of the Study:
- Investigate the role of TP promoter methylation in regulating TP expression in human cancer cell lines.
- Determine the impact of methylation on TP gene silencing.
- Explore potential therapeutic strategies targeting TP methylation.
Main Methods:
- TP promoter methylation analysis using bisulfite sequencing.
- Quantification of TP mRNA levels via real-time quantitative PCR.
- Assessment of TP promoter activity using Luciferase reporter assays.
- Evaluation of DNA-protein interactions with electrophoretic mobility shift assays.
Main Results:
- TP expression varied significantly across cell lines, with DLD-1 showing no expression and SKBR-3 showing high expression.
- Extensive promoter methylation correlated with absent TP expression in DLD-1 cells.
- Methylation inhibition (5-aza-2dC) reactivated TP expression in DLD-1 cells, enhanced by histone deacetylase inhibition (Trichostatin-A).
- Methylation inhibited transcription factor binding, implicating Sp1 and Sp3 in TP regulation.
Conclusions:
- TP promoter methylation is a key mechanism for down-regulating TP expression in cancer.
- Reactivation of TP through methylation inhibition shows potential for cancer therapy.
- TP methylation status may serve as a prognostic biomarker in cancer patients.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells
Somatic cells are...

